Respiratory viruses: New frontiers-a Keystone Symposia report
Authors list
Jennifer Cable Jie Sun In Su Cheon Andrew E Vaughan Italo A Castro Sydney R Stein Carolina B López Katelyn M Gostic Peter JM Openshaw Ali H Ellebedy Andreas Wack Edward Hutchinson Mallory M Thomas Ryan A Langlois Daniel Lingwood Steven F Baker Melanie Folkins Ellen F Foxman Andrew B Ward Martin Schwemmle Alistair B Russell Christopher Chiu Ketaki Ganti Kanta Subbarao Timothy P Sheahan Pablo Penaloza-MacMaster Taylor Eddens Toggle all authors (27)
Abstract
Respiratory viruses are a common cause of morbidity and mortality around the world. Viruses like influenza, RSV, and most recently SARS-CoV-2 can rapidly spread through a population, causing acute infection and, in vulnerable populations, severe or chronic disease. Developing effective treatment and prevention strategies often becomes a race against ever-evolving viruses that develop resistance, leaving therapy efficacy either short-lived or relevant for specific viral strains. On June 29 to July 2, 2022, researchers met for the Keystone symposium "Respiratory Viruses: New Frontiers." Researchers presented new insights into viral biology and virus-host interactions to understand the mechanisms of disease and identify novel treatment and prevention approaches that are effective, durable, and broad.
Journal details
Volume 1522
Issue number 1
Pages 60-73
Available online
Publication date
Full text links
Publisher website (DOI) 10.1111/nyas.14958
Europe PubMed Central 36722473
Pubmed 36722473
Keywords
Related topics
Type of publication